ArticleFrontiers in pharmacology2024

Tilianin suppresses NLRP3 inflammasome activation in myocardial ischemia/reperfusion injury via inhibition of TLR4/NF-κB and NEK7/NLRP3.

Suyue Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.